364 related articles for article (PubMed ID: 17197427)
1. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.
Ries C; Egea V; Karow M; Kolb H; Jochum M; Neth P
Blood; 2007 May; 109(9):4055-63. PubMed ID: 17197427
[TBL] [Abstract][Full Text] [Related]
2. RECK (reversion-inducing cysteine-rich protein with Kazal motifs) regulates migration, differentiation and Wnt/β-catenin signaling in human mesenchymal stem cells.
Mahl C; Egea V; Megens RT; Pitsch T; Santovito D; Weber C; Ries C
Cell Mol Life Sci; 2016 Apr; 73(7):1489-501. PubMed ID: 26459448
[TBL] [Abstract][Full Text] [Related]
3. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
Wang C; Chen Z; Li Z; Cen J
Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
[TBL] [Abstract][Full Text] [Related]
4. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3.
De Becker A; Van Hummelen P; Bakkus M; Vande Broek I; De Wever J; De Waele M; Van Riet I
Haematologica; 2007 Apr; 92(4):440-9. PubMed ID: 17488654
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
[TBL] [Abstract][Full Text] [Related]
6. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
7. [Expression of gelatinases A and B and their endogenous regulators in immortal and transformed fibroblasts].
Solov'eva NI; Vinokurova SV; Ryzhakova OS; Gureeva TA; Tsvetkova IV
Biomed Khim; 2009; 55(4):441-50. PubMed ID: 20000122
[TBL] [Abstract][Full Text] [Related]
8. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
9. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
Dong Z; Nemeth JA; Cher ML; Palmer KC; Bright RC; Fridman R
Int J Cancer; 2001 Aug; 93(4):507-15. PubMed ID: 11477554
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells.
Neth P; Ciccarella M; Egea V; Hoelters J; Jochum M; Ries C
Stem Cells; 2006 Aug; 24(8):1892-903. PubMed ID: 16690780
[TBL] [Abstract][Full Text] [Related]
12. Substrate choice of membrane-type 1 matrix metalloproteinase is dictated by tissue inhibitor of metalloproteinase-2 levels.
Kudo T; Takino T; Miyamori H; Thompson EW; Sato H
Cancer Sci; 2007 Apr; 98(4):563-8. PubMed ID: 17425593
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
Schwandner O; Schlamp A; Broll R; Bruch HP
Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
[TBL] [Abstract][Full Text] [Related]
14. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.
Chernov AV; Sounni NE; Remacle AG; Strongin AY
J Biol Chem; 2009 May; 284(19):12727-34. PubMed ID: 19286653
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclic mechanical stretch on extracellular matrix synthesis by human scleral fibroblasts.
Shelton L; Rada JS
Exp Eye Res; 2007 Feb; 84(2):314-22. PubMed ID: 17123515
[TBL] [Abstract][Full Text] [Related]
17. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
[TBL] [Abstract][Full Text] [Related]
18. Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation.
Lluri G; Jaworski DM
Muscle Nerve; 2005 Oct; 32(4):492-9. PubMed ID: 16003733
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
Lu KV; Jong KA; Rajasekaran AK; Cloughesy TF; Mischel PS
Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
[TBL] [Abstract][Full Text] [Related]
20. MMP-14 and TIMP-2 overexpression protects against hydroquinone-induced oxidant injury in RPE: implications for extracellular matrix turnover.
Alcazar O; Cousins SW; Marin-Castaño ME
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5662-70. PubMed ID: 18055817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
